Rezolute, Inc.
NASDAQ:RZLTBiotechnology
+$0.30 today
- Market cap
- $411.10M
- Beta
- 0.65
- P/E (TTM)
- -6.5
- EPS (TTM)
- -$0.78
Volume 2.93M
Average 2.03M
RZLT Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Rezolute, Inc.NASDAQ: RZLT
Net Income · Q3 FY2026 · quarter ended Mar 2026
Net income dips below year-ago levels
Q3 FY2026 net income of $16.17M (cash outflow) fell 14.5% year over year, behind the +11.6% change in trailing-twelve-month net income. Sequentially, it fell 29.0% from the prior quarter. Over 3 fiscal years it compounded at +21.9% a year.
Context
- Net income grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 6 analysts of -$53.58M (-28.0%) for the fiscal year ending Jun 2026, a slowdown from the +8.7% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$16.17M-29.0% QoQ
- Last fiscal yearJun 2025
- -$74.41M+8.7% YoY
- LTMMar 2026
- -$81.49M+11.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -14.5% | -36.9% | -22.4 pp |
| 1 year | +8.7% | -28.0% | -36.7 pp |
| 3-year CAGR | +21.9% | -18.1% | -40.0 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (74.41M) USD
- Year-over-year change
- -8.7%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | (74.41M) | -8.7% |
| FY2024 | 2024-06-30 | (68.46M) | -32.2% |
| FY2023 | 2023-06-30 | (51.79M) | -26.1% |
| FY2022 | 2022-06-30 | (41.06M) | -96.4% |
| FY2021 | 2021-06-30 | (20.9M) | — |
Net Income vs competitors
How RZLT compares with its peers on the latest reported figures
- RZLT's LTM Mar 2026 net income of $81.49M is the 3rd largest of the 5 companies compared; the peer median is $3.4M.
- Its year-over-year change of +11.6% is the 3rd highest of 5, against a peer median of +122.1%.
- Over three fiscal years its annual growth of +21.9% compares with a peer median of -42.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $608.92M | +10.8% | -6.7% | 91.0% | |
| LTM Mar 2026 | $122.65M | +233.3% | — | 100.3% | |
| LTM Mar 2026 | $81.49M | +11.6% | +21.9% | — | |
| LTM Mar 2026 | $14.61M | +298.9% | -42.4% | 4.0% | |
| LTM Mar 2026 | $7.82M | -83.8% | -48.7% | 911.1% | |
| Peer median (excluding RZLT) | $3.4M | +122.1% | -42.4% | 95.6% | |
Competitors are the stored peer set for RZLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | (20.9M) | (41.06M) | (51.79M) | (68.46M) | (74.41M) |
| Depreciation & Amortization | 13K | 13K | 30K | 36K | 31K |
| Deferred Income Tax | (1.78M) | 0 | (1.37M) | 0 | 0 |
| Stock-Based Compensation | 3.97M | 3.69M | 7.27M | 7.36M | 7.12M |
| Change in Working Capital | (2.12M) | (642K) | 1.02M | 3.1M | 47K |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 142K | (11K) | 2.14M | 1.08M | 1.42M |
| Other Working Capital | (2.26M) | (631K) | (1.12M) | 2.02M | (1.37M) |
| Other Non-Cash Items | 384K | (1.61M) | 352K | 595K | (1.86M) |
| Operating Cash Flow | (20.44M) | (39.62M) | (44.48M) | (57.37M) | (69.08M) |
| Capital Expenditures | 0 | 0 | (153K) | 0 | 0 |
| Acquisitions (Net) | 0 | 0 | 101.46M | 0 | 0 |
| Purchases of Investments | 0 | 0 | (107.31M) | (66.4M) | (128.14M) |
| Sales of Investments | 0 | 0 | 6M | 115.1M | 113.6M |
| Other Investing Activities | 0 | 0 | (101.46M) | 0 | 0 |
| Investing Cash Flow | 0 | 0 | (101.46M) | 48.7M | (14.54M) |
| Debt Repayment | 15M | (16.01M) | 0 | 0 | 0 |
| Common Stock Issued | 41M | 122.82M | 12.33M | 49.02M | 107.33M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4.47M) | 31.39M | (759K) | 14.01M | 0 |
| Financing Cash Flow | 51.53M | 148.98M | 11.57M | 63.03M | 107.33M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 31.09M | 109.36M | (134.37M) | 54.36M | 23.71M |
| Free Cash Flow | (20.44M) | (39.62M) | (44.63M) | (57.37M) | (69.08M) |
Rezolute, Inc.
NASDAQ:RZLT
Intrinsic Alpha fair value
Locked
Current Price
$4.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.